These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 11869017)
1. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p53 expression in Wilms' tumor in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734 [TBL] [Abstract][Full Text] [Related]
3. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour. Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718 [TBL] [Abstract][Full Text] [Related]
4. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance. Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182 [TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen in Wilms' tumor. Chen F; Liu G; Zhang Z; Li Z; Cai W Chin Med J (Engl); 1997 May; 110(5):352-3. PubMed ID: 9594301 [TBL] [Abstract][Full Text] [Related]
6. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542 [TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative activity in Wilms' tumour. Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823 [TBL] [Abstract][Full Text] [Related]
8. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour. Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody]. Juszkiewicz P Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children. Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122 [TBL] [Abstract][Full Text] [Related]
11. C-kit protein expression in Wilms' tumour: an immunohistochemical study. Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635 [TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour. Taran K; Sitkiewicz A; Andrzejewska E; Kobos J Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463 [TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. Delahunt B; Bethwaite PB; Nacey JN; Ribas JL J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046 [TBL] [Abstract][Full Text] [Related]
14. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study. Ora I; van Tinteren H; Bergeron C; de Kraker J; Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075 [TBL] [Abstract][Full Text] [Related]
15. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour). Nowicki M; Ostalska-Nowicka D; Kaczmarek M; Miskowiak B; Witt M Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131 [TBL] [Abstract][Full Text] [Related]
16. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma]. Schönborn I; Minguillon C; Reles A; Bartel U; Lichtenegger W Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors. Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299 [TBL] [Abstract][Full Text] [Related]
18. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485 [TBL] [Abstract][Full Text] [Related]
19. [Anaplastic type of Wilms' tumour]. Vujanić GM; Aleksandrović S Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350 [TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]